The 3Q24 results are slightly above our expectations on the back of an improved operating margin. The guidance of EUR 1.15 EPRA EPS is reiterated. Home invest is one of the best performers to date among Belgian REITs. However, in the last month there was profit taking and negative news on regulation. As of 01/11/2024, rent increases in Brussels (66% portfolio) are on hold for 9 consecutive years. This was already the case for the 3-6-9 contracts but now impacts short term contracts and tenant de...
EVS indicated that after 3Q24 they are on track to achieve FY24 revenue and profit at the higher end range of its guidance (revenue guidance of € 190 to €200m (KBCSe € 197.1m) and EBIT guidance €40 to 46m (KBCSe € 44.1m)). Next to the positive impact of its revenue performance on its gross profit, EVS sees an increasing gross margin performance on all its solutions. For this EVS refers to a well balanced pricing strategy. Without giving exact numbers, they highlight that this results in an overa...
Bekaert - Update on the Liquidity Agreement Update on the Liquidity Agreement Period from 7 November 2024 to 13 November 2024 Liquidity agreement In relation to the renewed liquidity agreement with Kepler Cheuvreux announced on , Bekaert announces today that Kepler Cheuvreux on behalf of Bekaert has bought 8 800 shares during the period from 7 November 2024 to 13 November 2024 on Euronext Brussels. During the same period, Kepler Cheuvreux on behalf of Bekaert has sold 6 896 shares on Euronext Brussels. The tables below provide an overview of the transactions under the liquidity agreem...
Bekaert - Mise à jour relative au Contrat de liquidité Mise à jour relative au Contrat de liquidité Période allant du 7 novembre 2024 au 13 novembre 2024 Contrat de liquiditéDans le cadre du contrat de liquidité reconduit avec Kepler Cheuvreux annoncé le , Bekaert annonce aujourd'hui que Kepler Cheuvreux a acheté 8 800 actions pour le compte de Bekaert durant la période comprise entre le 7 novembre 2024 et le 13 novembre 2024 sur Euronext Bruxelles. Au cours de la même période, Kepler Cheuvreux a vendu 6 896 actions pour le compte de Bekaert sur Euronext Bruxelles. Les tableaux ci-dess...
Bekaert - Update over de Liquiditeitsovereenkomst Update over de Liquiditeitsovereenkomst Periode van 7 november 2024 tot 13 november 2024 Liquiditeitsovereenkomst In het kader van het hernieuwde liquiditeitscontract met Kepler Cheuvreux aangekondigd op , maakt Bekaert vandaag bekend dat Kepler Cheuvreux namens Bekaert 8 800 aandelen heeft aangekocht in de periode van 7 november 2024 tot 13 november 2024 op Euronext Brussels. Tijdens dezelfde periode heeft Kepler Cheuvreux namens Bekaert 6 896 aandelen verkocht op Euronext Brussels. De onderstaande tabellen geven een overzicht van ...
EVS Q3 2024 business update EVS Q3 2024 business update Reaffirming growth expectations for 2024, setting a new revenue high for EVS, while actively building the future Liège, Belgium | November 14th, 2024 EVS’ financial results are firming up in line with expectations. While the final weeks of production and deliveries are being planned, we primarily focus on building the future. Order intake for the fourth quarter looks promising, ensuring a kick start in 2025. We have significant commercial opportunities in the pipeline, which are bound to play a substantial role in our future suc...
We initiate coverage of Heijmans, a contractor focused on the Dutch market, with an Outperform rating and a TP of € 36.5 (DCF based). The Dutch residential market is finally recovering, and we believe Heijmans is well-positioned to benefit due to its land bank and property development arm, driving up revenues while EBITDA margins are expected to exceed 8.5% in the Living unit. Heijmans is also benefitting from strong demand from the infrastructure and energy markets, allowing for soli...
We initiate coverage of Heijmans, a contractor focused on the Dutch market, with an Outperform rating and a TP of € 36.5 (DCF based). The Dutch residential market is finally recovering, and we believe Heijmans is well-positioned to benefit due to its land bank and property development arm, driving up revenues while EBITDA margins are expected to exceed 8.5% in the Living unit. Heijmans is also benefitting from strong demand from the infrastructure and energy markets, allowing for soli...
Agfa-Geveart: Material miss on Healthcare activities. ASML: Long-term guidance confirmed. CVC Capital Partners: Comfortably on track. DEME Group: Raises outlook, lowers capex guidance. Proximus: Pressure on CEO from another possible coalition party. SBM Offshore: Again delivering
>Very strong Q3 sales: beat of 16% and yoy growth of 40% - In its Q3 sales and order book update, DEME reported sales of €1.16bn, a beat of 16% versus our estimate (no css available). That €1.16bn in sales also means YoY growth of 39.9%, a clear acceleration versus growth in the first 6 months of 2024 which amounted to 29.9%. Offshore Energy did extremely well with YoY growth in Q3 of 86% (H1 2024 YoY growth was 38%) driven by higher capacity (fleet extensions) and hi...
We maintain our Buy rating and € 175 Target Price as DEME continues to see strong tender activity and a robust pipeline fuelled by solid demand across all contracting segments. 3Q24 sales came in at € 1.07bn (+34.8% y/y) and 9M24 revenues grew 32% y/y nearly € 3 bn with very solid double-digit growth in both the Offshore Energy and Dredging & Infra segments, boosted by continued high activity levels and effective project execution in 3Q24. Given this very nice 9M24 performance and taking into ac...
Trading update Q3 2024: heading toward a record turnover in 2024 Highlights third quarter 2024 Group turnover grew 32% in the first nine months of the year, reaching nearly 3 billion euro, up from 2.3 billion euro in the same period last yearOrderbook remains at a healthy level at 7.1 billion euroManagement further revised its guidance upward, now projecting year-over-year turnover growth to exceed 20%, with an EBITDA margin comparable to 2023 Attachment
Trading update Q3 2024: op weg naar een recordomzet in 2024 Hoogtepunten derde kwartaal 2024 In de eerste negen maanden van het jaar steeg de groepsomzet met 32% tot bijna 3 miljard euro in vergelijking met een omzet van 2,3 miljard euro in dezelfde periode vorig jaarHet orderboek blijft gezond op een niveau van 7,1 miljard euroHet management heeft zijn verwachtingen voor het jaar naar boven bijgesteld, en verwacht nu een jaar over jaar omzetgroei die de 20% zal overschrijden, met een EBITDA-marge vergelijkbaar met die van 2023 Bijlage
Yesterday before US market opens, argenx and partner Zai Lab announced China's national medical products administration (NMPA) approved the supplemental (sBLA) for Vyvgart Hytrulo in adults with CIDP. We anticipate approx. $600m in peak sales for CIDP in China, and pencil down 15% royalties to argenx from Zai Lab. Looking ahead, the candidate has been submitted to regulatory agencies in Europe and Japan, with approvals in CIDP expected in 2025, while regulatory submission in Canada is due by YE2...
argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China First and only NMPA-approved treatment for patients with CIDP in China Second VYVGART Hytrulo indication approved in China November 11, 2024 – 7:30am ET Amsterdam, the Netherlands— argenx SE (Euronext & Nasdaq: ARGX) and Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) approved the supplemental Biologics License Application (sBLA) for VYVGART Hytrulo 1,000mg (5.6ml)/vial [efgartigimod alfa inject...
Arcadis reports transactions under its current share buyback program Arcadis reports transactions under its current share buyback program Amsterdam, November 11, 2024 – Arcadis (EURONEXT: ARCAD), the leading data driven global Design & Consultancy organization for natural and built assets, has repurchased 39,537 of its own shares in the period 4 November – 8 November 2024 at an average price of €65.18. The total consideration of this repurchase was €2,576,847. The repurchase is in accordance with the share buyback program to cover existing and expected future obligations under Arcadis’ ...
Bekaert - Update on the Liquidity Agreement Update on the Liquidity Agreement Period from 31 October 2024 to 6 November 2024 Liquidity agreement In relation to the renewed liquidity agreement with Kepler Cheuvreux announced on , Bekaert announces today that Kepler Cheuvreux on behalf of Bekaert has bought 7 600 shares during the period from 31 October 2024 to 6 November 2024 on Euronext Brussels. During the same period, Kepler Cheuvreux on behalf of Bekaert has sold 5 904 shares on Euronext Brussels. The tables below provide an overview of the transactions under the liquidity agreemen...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.